Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Effimune

Effimune
2007 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
$30.6M LATEST DEAL AMOUNT
Description

Developer of drug candidates for transplantation and immune-mediated diseases. The company is engaged in the research and development of biological drug candidates targeting cells of the immune system to restore the balance between effector and regulatory mechanisms.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Faculté de Médecine
  • 1 Rue Gaston Veil
  • 44035 Nantes
  • France

+33 02 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Effimune’s full profile, request a free trial.

Effimune Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 24-Feb-2016 $30.6M 00.000 000.00 Completed Generating Revenue
2. Early Stage VC 10-Mar-2015 00.000 00.000 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Effimune Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Debiopharm Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
Inserm Transfert Initiative Venture Capital Minority 000 0000 000000 0

Effimune Executive Team (3)

Name Title Board
Seat
Contact
Info
Anne-Laure Autret-Cornet Financial manager
Bernard Vanhove Ph.D Chief Executive Officer & Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

Effimune Board Members (5)

Name Representing Role Since Contact
Info
Didier Hoch Self Board Member 000 0000
Elisabeth Hubert MD Self Board Member 000 0000
Maryvonne Hiance OSE Immunotherapeutics Chairman & Co-Founder 000 0000
Pierre Germain Ph.D Self Board Member 000 0000
Sophie Brouard Ph.D Effimune Co-Founder & Board Member 000 0000